Insider Trading & Ownership - LEDERMAN SETH

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for LEDERMAN SETH
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-29
Purchase
2022-07-01
4:05 pm
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
20,000$1.71$34,20027,754
(Indirect
Direct)
View
2022-03-25
Purchase
2022-03-28
08:00 am
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
100,000$0.245$24,500248,024
(Indirect
Direct)
View
2021-09-28
Purchase
2021-09-28
5:04 pm
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
12,000$0.61$7,320148,024
(Indirect
Direct)
View
2021-03-24
Purchase
2021-03-25
07:00 am
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
16,733$1.32$22,088136,024
(Indirect
Direct)
View
2020-12-30
Purchase
2021-01-04
5:01 pm
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
35,000$0.68$23,800119,291
(Indirect
Direct)
View
2020-08-13
Purchase
2020-08-17
09:03 am
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
60,000$0.91$54,60084,291
(Indirect
Direct)
View
2019-12-03
Purchase
2019-12-04
07:00 am
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
20,000$1.159$23,18024,291
(Indirect
Direct)
View
2019-03-29
Purchase
2019-04-01
08:22 am
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
5,000$2.488$12,44042,883
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-27
Option Award(A)
2024-03-06
5:01 pm
2025-02-27
2034-02-27
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
3,448,911$03,448,911
(Direct)
View
2024-02-27
Option Award
2024-02-29
5:08 pm
2025-02-27
2034-02-27
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
3,448,911$03,448,911
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:34 pm
2024-02-23
2033-02-23
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
1,400,000$01,400,000
(Direct)
View
2022-02-15
Option Award
2022-02-17
5:17 pm
2023-02-15
2032-02-15
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
20,000,000$020,000,000
(Direct)
View
2021-02-23
Option Award
2021-02-25
5:54 pm
2022-02-23
2031-02-23
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
6,000,000$06,000,000
(Direct)
View
2020-05-04
Option Award
2020-05-06
6:22 pm
2021-05-04
2030-05-04
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
4,000,000$04,000,000
(Direct)
View
2020-02-25
Option Award
2020-02-27
4:22 pm
2021-02-25
2030-02-25
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
240,000$0240,000
(Direct)
View
2019-05-06
Option Award
2019-05-08
08:01 am
2020-05-06
2029-05-06
Tonix Pharmaceuticals Holding Corp.TNXPLEDERMAN SETH
Chief Executive Officer
259,515$0259,515
(Direct)
View
(A) Indicate amendment filing.